207.
Laight D. W. Antioxidants, diabetes and endothelial dysfunction / D. W.
Laight, M. J. Carrier, E. E. Anggard // Cardiovasc. Res. – 2000. – Vol. 47. – P.
457-464.
208.
Lamon B. D. Inflammation at the Molecular Interface of Atherogenesis / B. D.
Lamon, D. P. Hajjar // Am. J. Pathol. – 2008. – Vol. 173, № 5. – 1253-1264.
209.
Landsberg L. Insulin-mediated sympathetic stimulation: role in the
pathogenesis of obesity-related hypertension / L. Landsberg // J. Hypertens. –
2001. – Vol. 19. – P. 523-528.
210.
Leptin and cardiovascular disease: response to therapeutic interventions / K. K.
Koh [et al.] // Circulation. – 2008. – Vol. 117. – P. 3238-3249.
211.
Leptin and coronary heart disease, prospective study and systematic review /
N. Sattar [et al.] // J. Am. Coll. Cardiol. – 2009. – Vol. 53, № 2. – P.167-175.
212.
Leptin and Hypertension in Obesity / P. E. Bravo [et al.] // Vasc. Health Risk
Manag. – 2006. – Vol. 2, № 2. – P. 163-169.
213.
Leptin and other components of the Metabolic syndrome in Mauritius: a factor
analysis / A. M. Holge [et al.] // Int. J. Obes. – 2001. – № 25. – P. 126-131.
214.
Leptin association with erythrocyte sodium content in obesity-related
hypertension / S. G. Barroso [et al.] // Trace Elem. Eletrolytes. – 2003. – Vol. 20.
– P. 134-139.
215.
Leptin binding activity changes with age: the link between leptin and puberty /
N. D. Quinton [et al.] // J. Clin. Endocrinol. Metab. – 1999. – Vol. 84, № 7. – P.
23-36.
216.
Leptin hormonal kinetics in the fed state: effects of adiposity, age, and gender
on endogenous leptin production and clearance rates / S. L. Wong [et al.] // J.
Clin. Endocrinol. Metab. – 2004. – Vol. 89. – P. 2672-2677.
217.
Leptin is released from the human brain: influence of adiposity and gender / G.
Wiesner [et al.] // J. Clin. Endocrinol. Metab. – 1999. – Vol. 84. – P. 2270-2274.
